©2022 Australasian Society of Clinical Immunology and Allergy (ASCIA)
ABN 45 615 521 452


Research Studies

Centre for Food and Allergy Research (CFAR)

The CFAR website lists studies that are currently accepting participants in Australia:

Biomedical and complementary medicine (CM) use in adults with eosinophilic oesophagitis (EoE)  - Survey

Are you living with eosinophilic esophagitis (EoE)? This international survey is being conducted by researchers from Southern Cross University (Australia) to understand what therapies adults with EoE use to manage their symptoms. The findings of this study will help identify potential treatment options for people living with EoE that could be examined further through clinical research. Visit  to find out more about the survey.

Ocular Allergy Survey

A research team at Deakin University is currently conducting a short survey which aims to assess health practitioner diagnostic, treatment, and collaborative care approach to Ocular Allergy. This study has received Deakin University ethics approval (reference number: SEBE-2020-68-MOD01) and we would appreciate your involvement.

The survey link is

You are eligible to take part in this study if you are an Ophthalmologist, Pharmacist, Optometrist, General Practitioner, or Allergist, who is AHPRA registered and practicing in Australia. You are ineligible if you are in these health fields but are not fully qualified (i.e. students, interns, residents, registrars, and/or in training) or are any other health practitioner not mentioned above.  Participation is confidential and voluntary. You are under no obligation to take part. By clicking the link above, you will be directed to the short survey that can be completed from the comfort of your phone, or laptop/computer.

Seasonal Hay fever (Allergic Rhinitis) Study

There is a clinical study for an investigational nasal spray which is being investigated for the reduction of symptoms of hay fever (allergic rhinitis). The nasal spray is drug-free, and all ingredients of the formulation are well-established and generally recognized as safe.

If the study is of interest to you, please register your details at:

VIC (Camberwell)  -

NSW (Darlinghurst) -

QLD (Fortitude Valley) -

Peanut Oral Immunotherapy (OIT) Trial for People Over 16 Years

St Vincent’s Hospital Sydney is recruiting to an Australia-first research trial to help people over 16 years of age, who are living with peanut allergy. We are investigating the effectiveness of combining omalizumab with peanut oral immunotherapy in improving safety and tolerability of peanut immunotherapy in adults. This will not cure peanut allergy, but aims to improve safety and quality of life for those living with peanut allergy into adulthood.

We are seeking participants who are:
-           over the age of 16 and have peanut allergy
-           have not been admitted to ICU for a peanut reaction in the last 5 years
-           not lactating, pregnant or planning pregnancy 
-           and able to commit to 18 study visits over 12 months (7 of the visits take between 4 to 6 hours) 

Prospective participants and their referrers can contact us by email at This email address is being protected from spambots. You need JavaScript enabled to view it.. Include your phone number and the best time for a member of the study team to contact you. Information can also be found at

Allergy and Immunology Foundation of Australasia (AIFA)

AIFA - ACNC Registered Charity OrganisationAIFA was established in 2013 by ASCIA to fund medical research into allergy and other immune diseases. Donate to AIFA at  

For information about research projects funded by AIFA grants go to 

Content updated June 2022